Craig Dickinson Email

VP US Sales . 4DMedical

Current Roles

Employees:
170
Revenue:
$42.7M
About
Despite our rapidly increasing understanding of lung disease, our ability for effective treatments is critically limited by the lack of tools to measure lung function in a regional manner. Nearly all lung pathologies are associated at the onset of disease with subtle, significant and regional changes in airflow due to changes in tissue compliance and/or resistance. However, the current gold standard diagnostics can only measure pulmonary capacity as an average over the entire lung. As a result, a diagnosis can often come too late because for a loss of lung function to even be measurable, the disease must be well-advanced. Now, for the first time in medical history, the capacity to simply, safely and effectively view and measure regional lung function is here. We are 4DMedical - the medical technology company responsible for the XV Lung Ventilation Analysis Software - the breakthrough lung imaging technology that quantitatively measures the patterns of regional lung function in 4D.
4DMedical Address
700 Swanston St
Melbourne, null
Australia
4DMedical Email

Past Companies

4DMedicalVice President of US Sales
GE HealthcareStrategic Development Leader - National OBL/ASC Segment
GE HealthcareInterventional Zone Modality Leader

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.